Table 4.
Mesh | Native tissue | Risk difference (95%CI) | |
---|---|---|---|
Indicated on questionnaire (intention-to-treat analysis) | |||
Questionnaires (n) | 66 | 72 | |
Pain: yes | 26 (39) | 36 (50) | −11 (−27, 6) |
• UDI pain score | 16.2 (16.2, 16.2) | 20.2 (18.6, 21.8) | −4.1 (−11.3, 3.1) |
• Estimated pain score after MI | 17.8 (13.0, 22.6) | 18.9 (14.6, 23.3) | −1.1 (−7.5, 5.2) |
Having sexual intercourse | 30 (46) | 30 (42) | 4 (−13, 20) |
Indicated on questionnaire (per-protocol analysis) | |||
Questionnaires (n) | 72 | 66 | |
Pain: yes | 29 (40) | 33 (50) | −10 (−26, 7) |
Data presented as n (%) or mean (95% CI)
MI multiple Imputation, UDI pain score Urogenital Distress Inventory, range 0–100, CI confidence interval
At 7 years, 9 native tissue patients received mesh: 8 were transvaginal mesh (TVM), of whom 6 completed the questionnaire